Unsupervised Analysis Uncovers Changes in Histopathologic Diagnosis in Supervised Genomic Studies
|
|
- David Ross
- 5 years ago
- Views:
Transcription
1 Technology in Cancer Research and Treatment ISSN Volume, Number 2, April (2006) Adenine Press (2006) Unsupervised Analysis Uncovers Changes in Histopathologic Diagnosis in Supervised Genomic Studies Human gastrointestinal stromal tumors () have recently emerged as a distinct mesenchymal tumor type that has a unique phenotype characterized by a gain of function mutations in c-kit. In contrast, leiomyosarcomas (LMS) of the gastrointestinal tract or retroperitoneum, which were previously classified together with s as gastrointestinal sarcomas, have much less frequent mutations of c-kit. We performed microarray analyses to gain a comprehensive understanding of the difference between the two types of soft-tissue sarcomas at the level of gene expression. Microarray experiments were performed on 0 s and 0 LMSs that were collected at the time of surgical resection. These tumors were categorized based on the histopathologic diagnosis recorded in our institutional database. Prior to our search for genes that are differentially expressed between these two types of cancers, we first carried out an unsupervised analysis using multidimensional scaling (MDS) to determine whether the two groups have marked overall differences in gene expression. Initially, the MDS did not reveal a good separation between the two groups. We then re-reviewed the histopathology of these tumors and realized that some of the cases included in our study were acquired 10 years ago when the diagnosis of gastrointestinal sarcoma was made according to histopathologic criteria alone without immunohistochemistry for c-kit. An experienced pathologist reviewed all of the specimens and this revealed that a number of the cases were classified as LMS in the clinical database. Correction of the histopathologic diagnosis and relabeling of the samples resulted in a much more pronounced separation of and LMS in the MDS analysis. This study underscores the need to re-review histopathology as reclassification occurs. While updating the clinical database may be desired, this is usually impractical. For molecular studies that use archival samples, it is critical to have the archival samples re-reviewed by a pathologist. Further, unsupervised analysis often proves to be a critical quality control step in identifying structural problems that may exist. Finally, MDS analysis further supports that is a distinct type of sarcoma. Matti Nykter, M.Sc. Kelly K. Hunt, M.D. 2 Raphael E. Pollock, M.D., Ph.D. 2 Adel K. El-Naggar, M.D. 1 Ellen Taylor, B.S. 1 Ilya Shmulevich, Ph.D. 4 Olli Yli-Harja, Ph.D. Wei Zhang, Ph.D. 1 1 Departments of Pathology and 2 Surgical Oncology The University of Texas M. D. Anderson Cancer Center Houston, Texas Institute of Signal Processing Tampere University of Technology 720 Tampere, Finland 4 Institute for Systems Biology Seattle, Washington Key words: Microarray; Database; Quality control; ; ; and MDS. Introduction Cancers are classified in different categories based on their site of origin and histopathologic features. While classification for hematologic, epithelial, and mesenchymal types of cancer is usually straightforward, subclassification within each of these categories can be challenging for the pathologist. For example, lymphomas can be categorized as Hodgkin s and non-hodgkin s lymphomas; non-hodgkin s lymphomas can further be classified as follicular, B-cell, et cetera (1). * Corresponding Author: Wei Zhang, Ph.D. wzhang@mdanderson.org 177
2 178 Nykter et al. As new discoveries are made that allow for improved classification systems, new subgroups of tumors can emerge or the existing groups can be redefined (1). While revised classifications increase the possibilities for additional treatment options, this also creates challenges for clinicians and pathologists who store the data based on currently available classification schemes. Clinical and pathologic information for each patient is generally stored in a clinical database that uses broad classifications for clinical information. At the time of initial surgical resection, the tumors are analyzed in detail and the information regarding the tumor is stored in the database. As additional information becomes available, tumors may be studied and reclassified based on the new information. However, it is impractical to recode all of this information in clinical databases. The correct classification of tumor types is important for clinical management and therapy because even when the cancer types appear to be very similar based on standard histopathology, unique molecular features may render the tumor sensitive or resistant to different therapies. While in some cases the classification of tumor types is obvious based on their morphology, this is not always the case. Recent studies have shown that in the independent reevaluation by different pathologists, the diagnoses are not always in consensus (2, ). This is mainly because the classification of the cancer types is now frequently based on both morphologic and immunohistochemical differences. Microarray experiments are being increasingly utilized in cancer research. In order to conduct a successful microarray experiment yielding conclusive results, a large number of samples need to be obtained. This is a major challenge for investigators who study rare tumor types, such as sarcomas of the gastrointestinal tract (4-6). Thus, conducting an experiment requires the utilization of all the samples that are available. This may include samples obtained over several decades that have been extracted and classified using different clinical and pathologic features. If new knowledge about the cancer types has changed the classification system, then the data obtained from clinical databases may be inaccurate and may yield incorrect conclusions. can be used as a quality control tool for the clinical and biological aspects of datasets. Materials and Methods We used Agilent human whole-genome microarray chips in our experiments. Tumor specimens from 60 patients were obtained, of which 0 were labeled as LMS and 0 were labeled as, in our institutional database (Table I). These samples were collected and hybridized during a -month period. RNA was isolated using the RNeasy Mini Kit (Qiagen Inc., Valencia, CA) after the tissues were ground to powder under frozen conditions and lysed in the lysis buffer TRI Reagent (Molecular Research Center, Inc., Cincinnati, OH). After preparation, samples were assigned randomly to the slides. For each slide, a sample from a and from a LMS was hybridized using different dyes. To avoid the possible effect of dye bias, dye colors were selected randomly for each slide (8). While the standard approach is to use one channel of the array for the experiment and another for the reference sample (8), we chose to hybridize two experiment samples to the same slide. As the quality of microarrays has improved, it has become more common to use intensity measurements directly in two-channel microarrays (e.g., Agilent microarray chips) ( 9, 10). Data from microarray slides were extracted using Agilent Feature Extraction software version 7..1 with default settings. The preprocessing done in Feature Extraction software which included Lowess normalization, was determined to be adequate (11, 12). After normalization, there were no observable biases between the samples due to the different slides or dyes (Figure 1). At the quality control phase, all control data was removed and all saturated values were replaced by the largest non-saturated expression value mea- Our case study exemplifies the need for pathologic re-review of banked tumor specimens prior to inclusion in microarray studies. Other investigators have also reported that a large number of gastrointestinal stromal tumors () have been misclassified as leiomyosarcomas (LMS) (7). We demonstrate here the importance of pathologic re-review when tumor samples are studied for molecular and genetic analysis. We show that false conclusions can be drawn from molecular studies when clinical information is inaccurate. Further, we propose that unsupervised learning Figure 1: Scatter plot from microarray data with dye swap. The samples labeled as R and G are taken from different slides. There is no visible bias due to the dye or slide. Technology in Cancer Research & Treatment, Volume, Number 2, April 2006
3 Unsupervised Analysis in Genomic Studies 179 Table I Overview of samples used in this study. Sample classification from our institutional database and the result of the pathological rereview are shown. Barcode Completed Number Surgery date Tissue type Initial diagnosis (institutional database) Diagnosis on re-review Small intestine, colon tumor normal mucosa Small intestine-tumor Stomach Stomach tumor Stomach, omentum, spleen, left diaphragm T-retroperitoneum, normal mucosa colon Abdomen-tumor Stomach-greater curve (esophagogastric junction) Retroperitoneum tumor , Metastasis Liver-, Metastasis Small bowel NORMAL, small bowel-4 nodules Stomach-tumor Tumor-stomach, Normal mucosa Chest wall/soft tissue of, chest Metastatic Ovary, uterus, Metastatic Small bowel mesenteric tumor Abdominal, colon Abdominal mass metastatic Segment of transverse Recurrent colon and intra abdominal tumor Retroperitoneum Colon Retroperitoneum-tumor, Kidney-normal Lt colon & stomach N-gallbladder, T- retroperitoneal Pelvic Retroperitoneum Bowel, normal mucosa Abdominal wall Abdomen-tumor Normal stomach, tumor T intra abdominal & prox sm bowel T-rectum, uterus, met N-sm Possible intestine high grade Normal-periteneum, adipose, Tumor Tumor-sm bowel, uterine, normal-sm bowel, mucosa Pelvic mass Favor leiomyosarcoma +++SMA Cy Dye Technology in Cancer Research & Treatment, Volume, Number 2, April 2006
4 180 Nykter et al. Table I Continued Overview of samples used in this study. Sample classification from our institutional database and the result of the pathological rereview are shown. Barcode Completed Number Surgery date Tissue type Initial diagnosis (institutional database) Diagnosis on re-review Pelvic mass omentum tumor Rectum Intraabdominal tumor, Mesentery tumor recurrent with peritoneal metastasis Liver met, liver normal, met Small bowel mesentery, recurrent tumor & normal Tumor, periadrenal retroperitoneal Retroperitoneum, metastasis Stomach-tumor Small bowel, tumorretropertoneum, normalcolon mucosa, colon wall Cy Dye sured for that specific gene. Finally, we had expression profiles of 41,67 genes available for the analysis. We used unsupervised analysis to analyze the obtained microarray data. It should be noted that instead of processing the data as ratios, we performed the analysis on the gene expression values directly (9, 10). We wanted to determine whether different cancer types could be separated based on gene expression data. Before unsupervised analysis can successfully be applied, genes with nearly constant expression profiles should be removed from the analysis as they are not likely to be informative. We computed the th and 9th percentiles for each gene expression on the log scale. If the ratio of these two statistics was less than two, the gene was deemed to be non-informative and removed. This filtering was done without any knowledge of the class labels using all the samples in the computation of the percentiles. After the filtering,,12 informative genes remained. Using these genes, classical multidimensional scaling (1) was applied with correlation as the distance measure. All the analyses were done using Matlab version 6.. Two-dimensional MDS representation of the microarray data with the class labels from our institutional database is shown in Figure 2. The spread of the and LMS populations is shown with the ellipses. The size of the ellipse is relative to the variance. Axes correspond to the direction that maximizes the variance within the populations. As the ellipses are significantly overlapping, all the samples seem to belong to one large cluster. We note that the ellipses should only be considered as a heuristic illustrative tool and do not reflect class separation obtained with real classification algorithms. Based on this result we might conclude that there is no visible separation between these two cancer types. Instead, the Results and Discussion Using multidimensional scaling, we can visualize the structure of the high-dimensional data in low-dimensional Euclidean space. Eigenvalue analysis (scree plot) of the MDS representation indicated that 2- dimensions are sufficient for data visualization (14). The first two and three dimensions included 2 and 4 percents of the total variance of all 60 dimensions, respectively. Since we have used MDS only as a data visualization tool, including the third dimension did not improve the visually observable class separation. Figure 2: Two dimensional MDS representation with labels from our institutional clinical database. Samples from patients with are denoted by squares and those from patients with LMS by circles. The spread of the populations is demonstrated by ellipses. Dashed and dotted ellipses correspond to LMS and, respectively. Ellipses are overlapping, thus there is no visible separation between LMS and. Technology in Cancer Research & Treatment, Volume, Number 2, April 2006
5 Unsupervised Analysis in Genomic Studies 181 majority of the samples are mixed together in one large cluster of points. This was surprising since there is usually some type of separation between different cancer types observed with an unsupervised analysis (1, 16). In addition, the distinction of and LMS based on microarray data has been reported earlier (6). This raised significant concerns regarding the validity of our analysis. After studying the data in more detail, the error source led back to the clinical and pathologic information from our institutional database. The earliest samples used for this experiment were over ten years old and thus, the clinical classification of these samples corresponded to the knowledge at that time. New knowledge about the classification of these mesenchymal tumors had not been incorporated into the institutional database since there had been no general pathologic re-review of samples in this histologic classification (7). In order to assign the clinical labels in a more accurate fashion, the samples were re-reviewed by a single pathologist. This pathologic re-review revealed that many of the samples had the wrong clinical label since they were classified according to the old histologic classification scheme (Table I). Of 0 samples that were originally classified as LMS, 11 were reclassified as. Thus, we actually had 41 samples that were and 19 that were LMS. The reason for such a significant reclassification was the new information revealing that have expression of CD117 whereas LMS tumors are positive for smooth muscle actin (7). The pathological features and c-kit and smooth muscle actin staining patterns for and LMS are shown in Figure. The same MDS representation with new corrected class labels is shown in Figure 4. While the class separation still is A C Figure : Composite photomicrograph of and LMS. (A) Profileration of mesenchymal cells with mild polymorphism (). (B) c-kit positive immunostaining in the cytoplasm of neoplastic cells. (C) A hematoxylin and eosin stain of LMS revealing interlacing bundeles of neoplastic spindle cells. (D) Positive smooth muscle actin in the cytoplasm of tumor cells of LMS. B D not perfect, we observed that the majority of the samples of same type are clustered together. If we compare this to the result in Figure 2, we observe that now the ellipse showing the spread of LMS population is smaller and the cluster is partially separate from the cluster. Thus, even though the separation is not perfect, LMS samples appear to be clustered in a cluster of their own. This shows that unsupervised analysis can potentially uncover underlying similarities between the samples from the same cancer type. Figure 4: Two dimensional MDS representation with labels after pathological re-review and validation. Samples from patients with are denoted by squares and those from patients with LMS by circles. The spread of the populations is demonstrated by ellipses. Dashed and dotted ellipses correspond to LMS and, respectively. There is a clear class separation as the samples from LMS are clustered in a small group that is separate from the cluster. Multidimensional scaling applied in this work is just one of the many unsupervised learning approaches proposed for gene expression studies. For example, different clustering methods (1, 16), such as hierarchical and k-means clustering, have been proposed for the same purpose. To get a more comprehensive understanding of the data, several different methods could be applied. If all unsupervised learning methods produce results that are inconsistent with the class labels, this would further strengthen the assumption that the labels are wrong. To demonstrate the effect of false class labels on supervised analysis, we performed a two-tailed t-test. As a result p- value for the significance of each gene was obtained. The number of differentially expressed genes is shown as a function of p-value in Figure for original, updated, and random class labels (17). As there are more differentially expressed genes with updated class labels, this indicates that the results obtained with supervised learning are consistent with the unsupervised approach. If the original class labels are used, the number of observed differentially expressed genes is closer to the number of genes observed using randomly selected class labels. With updated class labels, the num- Technology in Cancer Research & Treatment, Volume, Number 2, April 2006
6 182 Nykter et al. ber of observed differentially expressed genes is higher [17 genes after Bonferroni correction (14) for multiple testing] than with the original labels (8 genes). Figure : Number of differentially expressed genes shown as the function of p-value, obtained using a t-test. Data are shown for original and updated class labels. In addition, 1% and % significance levels are shown for p-values, obtained permuting class labels randomly 100 times. Shown p-values are raw p-values from the t-test (i.e., they have not been corrected to compensate for multiple testing). It is important to note that had we ignored the structural problems observed with unsupervised learning approaches and proceeded with the analysis, the results and conclusions would have been completely different and incorrect. For example, if we would have used supervised learning to construct classifiers with false class labels, we would have obtained a list of genes that may have no role in the true class separation. However, this error would not have been noticed prior to incurring time and expenses for laboratory experiments designed to validate such classifiers. Therefore, it is vital that the clinical labels are verified before any additional analyses are performed. This is especially true when older samples are used that have been classified using earlier classification schemes. Re-review of samples by a single pathologist or a team of pathologists using the same criteria for classification can ensure that a more homogeneous population is being examined. While unsupervised analysis can uncover new information from the data, it can also be used as a quality control tool for clinical information. If the findings of the unsupervised analysis are not consistent with the expected behavior, the investigator may find it prudent to question the initial clinical information. Acknowledgments This work was supported by a grant from NCI/NIH (CA09870 to WZ and REP). Support from National Technology Agency of Finland is gratefully acknowledged (MN and OY). References 1. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chan, J. K., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., et al. A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group. Blood 84, (1994). 2. Trotter, M. J. and Bruecks, A. K. Interpretation of Skin Biopsies by General Pathologists: Diagnostic Discrepancy Rate Measured by Blinded Review. Arch. Pathol. Lab. Med. 127, (200).. Xavier, A. C. G., Siqueira, S. A. C., Costa, L. J. M., Mauad, T., Saldiva, P. H. N. Missed Diagnosis in Hematological Patients an Autopsy Study. Virchows Archiv 446, (200). 4. Koh, J. S., Trent, J., Chen, L., El-Naggar, A., Hunt, K., Pollock, R., Zhang, W. Gastrointestinal Stromal Tumors: Overview of Pathologic Features, Molecular Biology, and Therapy With Imatinib Mesylate. Histol Histopathol. 19, 6-74 (2004).. Shmulevich, I., Hunt, K., El-Naggar, A., Taylor, E., Ramdas, L., Laborde, P., Hess, K. R., Pollock, R., Zhang, W. Tumor Specific Gene Expression Profiles in Human : An Evaluation of Intratumor Heterogeneity. Cancer 94, (2002). 6. Antonescu, C. R., Viale, A., Sarran, L., Tschernyavsky, S. J., Gonen, M., Segal, N. H., Maki, R. G., Socci, N. D., Dematteo, R. P., Besmer, P. Gene Expression in Gastrointestinal Stromal Tumors is Distinguished by KIT Genotype and Anatomic Site. Clin. Cancer. Res. 10, (2004). 7. De Schipper, J. P., Liem, R. S. L., Van den Ingh, H. F. G. M., Van der Harst, E. Revision of Gastrointestinal Mesenchymal Tumours with Cd117. Eur. J. Surg. 0, (2004). 8. Zhang, W., Shmulevich, I., Astola, J. Microarray Quality Control. John Wiley And Sons (2004). 9. Yang, Y. H., Thorne, N. Normalization for Two-color cdna Microarray Data, Science and Statistics: A Festschrift For Terry Speed, 40, pp Ed., D. Goldstein. Ims Lecture Notes, Monograph Series (200). 10. t Hoen, P. A. C., Turk, R., Boer, J. M., Sterrenburg, E., De Menezes, R. X., Van Ommen, G. B., Den Dunnen, J. T. Intensity-based Analysis of Two-colour Microarrays Enables Efficient and Flexible Hybridization Designs. Nucleic Acids Res. 2, E41 (2004). 11. Quackenbush, J. Microarray Data Normalization and Transformation. Nat. Genet. 2, (2002). 12. Shmulevich, I and Zhang, W. Binary Analysis and Optimizationbased Normalization of Gene Expression Data. Bioinformatics 18, -6 (2002). 1. Borg, I. and Groenen, P. J. F. Modern Multidimensional Scaling, Springer Series. In Statistics, 2nd Ed. (200). 14. Johnson, R. A. and Wichern, D. W. Applied Multivariate Statistical Analysis. Prentice Hall, 4th Ed. (1998). 1. Alon, U., Barkai, N., Notterman, D. A., Gish, K.,ybarra, S., Mack, D., Levine, A. J. Broad Patterns of Gene Expression Revealed by Clustering Analysis of Tumor and Normal Colon Tissues Probed by Oligonucleotide Arrays. Proc. Natl. Acad. Sci. USA 96, (1999). 16. Eisen, M. B., Spellman, P. T., Brown, P. O., Botstein, D. Cluster Analysis and Display of Genome-wide Expression Patterns. Proc. Natl. Acad. Sci. USA 9, (1998). 17. Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., Bloomfield, C. D., Lander, E. S. Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring. Science 286, 1-7 (1999). Received: October 1, 200; Revised: January, 2006; Accepted: January 12, 2006 Technology in Cancer Research & Treatment, Volume, Number 2, April 2006
A Strategy for Identifying Putative Causes of Gene Expression Variation in Human Cancer
A Strategy for Identifying Putative Causes of Gene Expression Variation in Human Cancer Hautaniemi, Sampsa; Ringnér, Markus; Kauraniemi, Päivikki; Kallioniemi, Anne; Edgren, Henrik; Yli-Harja, Olli; Astola,
More informationEvaluating and Reporting Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment
The Open Pathology Journal, 2009, 3, 53-57 53 Open Access Evaluating and Reporting Gastrointestinal Stromal Tumors after Imatinib Mesylate Treatment Katie L. Dennis * and Ivan Damjanov Department of Pathology
More informationData analysis in microarray experiment
16 1 004 Chinese Bulletin of Life Sciences Vol. 16, No. 1 Feb., 004 1004-0374 (004) 01-0041-08 100005 Q33 A Data analysis in microarray experiment YANG Chang, FANG Fu-De * (National Laboratory of Medical
More informationGene Selection for Tumor Classification Using Microarray Gene Expression Data
Gene Selection for Tumor Classification Using Microarray Gene Expression Data K. Yendrapalli, R. Basnet, S. Mukkamala, A. H. Sung Department of Computer Science New Mexico Institute of Mining and Technology
More informationRADIOFREQUENCY ABLATION
RADIOFREQUENCY ABLATION ELIZABETH DAVID M D FRCPC VASCULAR A ND INTERVENTIONAL RADIOLOGIST SUNNYBROOK HEALTH SCIENCES CENTRE GIST GASTROINTESTINAL STROMAL TUMORS Stromal or mesenchymal neoplasms affecting
More informationImages In Gastroenterology
Images In Gastroenterology Thong-Ngam D, et al. THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 105 Imaging of Gastrointestinal Stromal Tumors Pornpim Fuangtharnthip, M.D. Narumol Hargroove, M.D.
More informationIntroduction to Discrimination in Microarray Data Analysis
Introduction to Discrimination in Microarray Data Analysis Jane Fridlyand CBMB University of California, San Francisco Genentech Hall Auditorium, Mission Bay, UCSF October 23, 2004 1 Case Study: Van t
More informationEfficacy of the Extended Principal Orthogonal Decomposition Method on DNA Microarray Data in Cancer Detection
202 4th International onference on Bioinformatics and Biomedical Technology IPBEE vol.29 (202) (202) IASIT Press, Singapore Efficacy of the Extended Principal Orthogonal Decomposition on DA Microarray
More informationAffiliazione autori0. Riccardo Ricci Journal Club GIPAD, settore GIST Anatomia Patologica, Università Cattolica, Roma
GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases American Journal of Surgical Pathology, 2017, 41:577-585 Miettinen M*; Felisiak-Golabek
More informationAppendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound
EFSUMB Newsletter 87 Examinations should encompass the full range of pathological conditions listed below A log book listing the types of examinations undertaken should be kept Training should usually
More informationGene expression analysis for tumor classification using vector quantization
Gene expression analysis for tumor classification using vector quantization Edna Márquez 1 Jesús Savage 1, Ana María Espinosa 2, Jaime Berumen 2, Christian Lemaitre 3 1 IIMAS, Universidad Nacional Autónoma
More informationPathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON
Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma
More informationMachine Learning! Robert Stengel! Robotics and Intelligent Systems MAE 345,! Princeton University, 2017
Machine Learning! Robert Stengel! Robotics and Intelligent Systems MAE 345,! Princeton University, 2017 A.K.A. Artificial Intelligence Unsupervised learning! Cluster analysis Patterns, Clumps, and Joining
More informationQ: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?
Q&A Session for Collecting Cancer Data: Ovary Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report? A: We reviewed both the
More informationClassification of Neoplasms
Classification of Neoplasms ICD-10 Chapter 2, Neoplasms Codes C00-D48 Notes at beginning of Chapter 2 Classified by behaviour and site Correct use of Alphabetic index required Main terms Modifiers Table
More informationCase: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on
Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on imaging. There is no significant past medical history.
More informationEDUCATIONAL COMMENTARY CA 125. Learning Outcomes
EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian
More informationCorporate Medical Policy
Corporate Medical Policy Microarray-based Gene Expression Testing for Cancers of Unknown File Name: Origination: Last CAP Review: Next CAP Review: Last Review: microarray-based_gene_expression_testing_for_cancers_of_unknown_primary
More informationA COMBINATORY ALGORITHM OF UNIVARIATE AND MULTIVARIATE GENE SELECTION
5-9 JATIT. All rights reserved. A COMBINATORY ALGORITHM OF UNIVARIATE AND MULTIVARIATE GENE SELECTION 1 H. Mahmoodian, M. Hamiruce Marhaban, 3 R. A. Rahim, R. Rosli, 5 M. Iqbal Saripan 1 PhD student, Department
More informationNuclear morphometric study of Non- Hodgkin's Lymphoma (NHL)
Original Research Article Nuclear morphometric study of Non- Hodgkin's Lymphoma (NHL) Sridhar Reddy Erugula 1, P. Sujatha 2, Ayesha Sameera 3, B. Suresh Reddy 4, Jesudass Govada 5, G. Sudhakar 6, Kandukuri
More informationMODEL-BASED CLUSTERING IN GENE EXPRESSION MICROARRAYS: AN APPLICATION TO BREAST CANCER DATA
International Journal of Software Engineering and Knowledge Engineering Vol. 13, No. 6 (2003) 579 592 c World Scientific Publishing Company MODEL-BASED CLUSTERING IN GENE EXPRESSION MICROARRAYS: AN APPLICATION
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationOn the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles
On the Reproducibility of TCGA Ovarian Cancer MicroRNA Profiles Ying-Wooi Wan 1,2,4, Claire M. Mach 2,3, Genevera I. Allen 1,7,8, Matthew L. Anderson 2,4,5 *, Zhandong Liu 1,5,6,7 * 1 Departments of Pediatrics
More informationEvolution of Pathology
1 Traditional pathology Molecular pathology 2 Evolution of Pathology Gross Pathology Cellular Pathology Morphologic Pathology Molecular/Predictive Pathology Antonio Benivieni (1443-1502): First autopsy
More informationClassification of cancer profiles. ABDBM Ron Shamir
Classification of cancer profiles 1 Background: Cancer Classification Cancer classification is central to cancer treatment; Traditional cancer classification methods: location; morphology, cytogenesis;
More informationMalignant gastrointestinal stromal (GISTs) of the duodenum A rare occurrence: Case report
Malignant gastrointestinal stromal tumors (GISTs) of the duodenum Case Report ISSN: 2394-0026 (P) Malignant gastrointestinal stromal tumors (GISTs) of the duodenum A rare occurrence: Case report Kandukuri
More informationClinical Analysis of Diagnosis and Treatment of Gastrointestinal Stromal Tumors (Report of 96 Cases)
121 Clinical Analysis of Diagnosis and Treatment of Gastrointestinal Stromal Tumors (Report of 96 Cases) Yueliang Lou Xieliang Zhang Hua Chen Zhongli Zhan Cancer Hospital of Tianjin Medical University,
More informationComparison of discrimination methods for the classification of tumors using gene expression data
Comparison of discrimination methods for the classification of tumors using gene expression data Sandrine Dudoit, Jane Fridlyand 2 and Terry Speed 2,. Mathematical Sciences Research Institute, Berkeley
More informationObject Localization Procedure for Intratumoral Microvessel Density Estimation
Object Localization Procedure for Intratumoral Microvessel Density Estimation OVIDIU GRIGORE ANDRE PUGA Telecommunications and Multimedia Department INESC Porto Praça da Republica 93, 4050-497 Porto PORTUGAL
More informationA case of pedunculated intraperitoneal leiomyoma
Jichi Medical University Journal Chio Shuto Kuniyasu Soda Takayoshi Yoshida Fumio Konishi Abstract We report a very rare case of a pedunculated intraperitoneal leiomyoma in the parietal peritoneum of the
More informationGastrointestinal stromal tumor with KIT mutation in neurofibromatosis type 1
J Korean Surg Soc 2011;81:276-280 http://dx.doi.org/10.4174/jkss.2011.81.4.276 CASE REPORT JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Gastrointestinal stromal tumor with
More informationBarriers to Understanding
Behind the Scenes: The Critical Importance of Cancer Cell Pathology and the Pathologist Sherry T. Emery, M.D., Chief of Pathology Northeast Health System Barriers to Understanding Questions for 2010 What
More informationANTICANCER RESEARCH 28: (2008)
Comparative Analysis of Four Histopathological Classification Systems to Discriminate Benign and Malignant Behaviour in Gastrointestinal Stromal Tumors D. VALLBÖHMER 1, H.E. MARCUS 1, S.E. BALDUS 2, J.
More informationACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.
Companion Meeting of the International Society of Bone and Soft Tissue Pathology The Evolving Concept of Mesenchymal Tumors ALK FUSION-POSITIVE MESENCHYMAL TUMORS Jason L. Hornick, MD, PhD March 13, 2016
More informationT. R. Golub, D. K. Slonim & Others 1999
T. R. Golub, D. K. Slonim & Others 1999 Big Picture in 1999 The Need for Cancer Classification Cancer classification very important for advances in cancer treatment. Cancers of Identical grade can have
More informationInternational Journal of Scientific & Engineering Research, Volume 7, Issue 5, May ISSN Case Report Rare Case Of Small Bowel GIST
International Journal of Scientific & Engineering Research, Volume 7, Issue 5, May-2016 282 Case Report Rare Case Of Small Bowel GIST Shahaji G. Chavan, Sagar R. Ambre, Vinayak kshirsagar, Ashish Vashistha
More informationClinicopathologic Spectrum of Gastrointestinal Stromal Tumours; Six Years Experience at King Hussein Medical Center
Clinicopathologic Spectrum of Gastrointestinal Stromal Tumours; Six Years Experience at King Hussein Medical Center Sahem T. Alqusous MD*, Osama J. Rabadi MD, MRCS*, Ala D. Al Omari MD*, Nabeeha N.Abbasi
More informationAbstract. Introduction. Salah Abobaker Ali
Sensitivity and specificity of combined fine needle aspiration cytology and cell block biopsy versus needle core biopsy in the diagnosis of sonographically detected abdominal masses Salah Abobaker Ali
More informationMorphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens
ISPUB.COM The Internet Journal of Pathology Volume 12 Number 1 Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens C Rose, H Wu Citation C Rose, H Wu.. The Internet Journal of Pathology.
More informationVisualizing Cancer Heterogeneity with Dynamic Flow
Visualizing Cancer Heterogeneity with Dynamic Flow Teppei Nakano and Kazuki Ikeda Keio University School of Medicine, Tokyo 160-8582, Japan keiohigh2nd@gmail.com Department of Physics, Osaka University,
More informationReference No: Author(s) NICaN Drugs and Therapeutics Committee. Approval date: 12/05/16. January Operational Date: Review:
Reference No: Title: Author(s) Systemic Anti-Cancer Therapy (SACT) Guidelines for Gastro- Intestinal Stromal Tumours Dr Martin Eatock, Consultant Medical Oncologist & on behalf of the GI Oncologists Group,
More informationGreater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy
Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy Authors: Dr Gordon Armstrong, Dr Sue Pritchard 1. General Comments 1.1 Cancer reporting: Biopsies
More informationMesenchymal neoplasms of the gastrointestinal tract what s new? Newton ACS Wong Department of Histopathology Bristol Royal Infirmary
Mesenchymal neoplasms of the gastrointestinal tract what s new? Newton ACS Wong Department of Histopathology Bristol Royal Infirmary Talk plan Summary from 2010 talk. What s happened since 2010. GISTs
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationPredictive Biomarkers
Uğur Sezerman Evolutionary Selection of Near Optimal Number of Features for Classification of Gene Expression Data Using Genetic Algorithms Predictive Biomarkers Biomarker: A gene, protein, or other change
More informationPROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT
PROTOCOL SENTINEL NODE BIOPSY (NON OPERATIVE) BREAST CANCER - PATHOLOGY ASSESSMENT Author: Dr Sally Ann Hales On behalf of the Breast and pathology CNGs Written: March 2005 Reviewed by CNG: June 2009 &
More informationGastrointestinal stromal tumours - clinicopathological study
Original research article Gastrointestinal stromal tumours - clinicopathological study *Dr. Putrevu Venkata Gurunadha Raju, ** Dr. Kanwaljit Kaur *Professor, **Assistant Professor Department of Pathology,
More informationLeiomyosarcoma Of The Intestine With Osseous Differentiation- A Rare Presentation
International Journal Of Medical Science And Clinical Inventions Volume 2 issue 04 2015 page no. 866-871 ISSN: 2348-991X Available Online At: http://valleyinternational.net/index.php/our-jou/ijmsci Leiomyosarcoma
More informationSupplemental Information
Supplemental Information Prediction of Prostate Cancer Recurrence using Quantitative Phase Imaging Shamira Sridharan 1, Virgilia Macias 2, Krishnarao Tangella 3, André Kajdacsy-Balla 2 and Gabriel Popescu
More informationSSM signature genes are highly expressed in residual scar tissues after preoperative radiotherapy of rectal cancer.
Supplementary Figure 1 SSM signature genes are highly expressed in residual scar tissues after preoperative radiotherapy of rectal cancer. Scatter plots comparing expression profiles of matched pretreatment
More informationNature Methods: doi: /nmeth.3115
Supplementary Figure 1 Analysis of DNA methylation in a cancer cohort based on Infinium 450K data. RnBeads was used to rediscover a clinically distinct subgroup of glioblastoma patients characterized by
More informationBrief History. Identification : Past History : HTN without regular treatment.
Brief History Identification : Name : 陳 x - Admission : 94/10/06 Gender : male Age : 75 y/o Chief Complaint : Urinary difficulty for months. Past History : HTN without regular treatment. Brief History
More informationLN04 - Lymphoma Tissue Microarray
Reveal Biosciences offers Histochemical Staining, Immunohistochemistry (IHC), In Situ Hybridization (ISH), Whole Slide Imaging, and Quantitative Image Analysis on any TMA LN04 - Lymphoma Tissue Microarray
More informationAJCC 7th Edition Handbook Errata as of 9/21/10
5 81 Larynx ICD-O-3 Topography Codes Delete C32.3 Laryngeal cartilage 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.8 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.9 5
More informationL. Ziaei MS*, A. R. Mehri PhD**, M. Salehi PhD***
Received: 1/16/2004 Accepted: 8/1/2005 Original Article Application of Artificial Neural Networks in Cancer Classification and Diagnosis Prediction of a Subtype of Lymphoma Based on Gene Expression Profile
More informationMEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationLeiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin?
2015;111:808 812 Leiomyosarcoma: One Disease or Distinct Biologic Entities Based on Site of Origin? DAVID J. WORHUNSKY, MD, 1 MIHIR GUPTA, BS, 1 SEPIDEH GHOLAMI, MD, 1 THUY B. TRAN, MD, 1 KRISTEN N. GANJOO,
More informationNature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from
Supplementary Figure 1 SEER data for male and female cancer incidence from 1975 2013. (a,b) Incidence rates of oral cavity and pharynx cancer (a) and leukemia (b) are plotted, grouped by males (blue),
More informationUnit 1 Exploring and Understanding Data
Unit 1 Exploring and Understanding Data Area Principle Bar Chart Boxplot Conditional Distribution Dotplot Empirical Rule Five Number Summary Frequency Distribution Frequency Polygon Histogram Interquartile
More informationAnalysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors
Ann Surg Oncol DOI 10.1245/s10434-014-3632-7 ORIGINAL ARTICLE BONE AND SOFT TISSUE SARCOMAS Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy
More informationUnderstanding Your GIST Pathology Report
Gastrointestinal Stromal Tumor Understanding Your GIST Pathology Report Jason L. Hornick, MD PhD Harvard Medical School Brigham and Women's Hospital Alexander J.F. Lazar, MD PhD Sarcoma Research Center
More informationSimple Discriminant Functions Identify Small Sets of Genes that Distinguish Cancer Phenotype from Normal
Genome Informatics 16(1): 245 253 (2005) 245 Simple Discriminant Functions Identify Small Sets of Genes that Distinguish Cancer Phenotype from Normal Gul S. Dalgin 1 Charles DeLisi 2,3 sdalgin@bu.edu delisi@bu.edu
More informationFinal Project Report Sean Fischer CS229 Introduction
Introduction The field of pathology is concerned with identifying and understanding the biological causes and effects of disease through the study of morphological, cellular, and molecular features in
More informationA Biclustering Based Classification Framework for Cancer Diagnosis and Prognosis
A Biclustering Based Classification Framework for Cancer Diagnosis and Prognosis Baljeet Malhotra and Guohui Lin Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada T6G 2E8
More informationImaging of Gastrointestinal Stromal Tumors (GIST) Amir Reza Radmard, MD Assistant Professor Shariati hospital Tehran University of Medical Sciences
Imaging of Gastrointestinal Stromal Tumors (GIST) Amir Reza Radmard, MD Assistant Professor Shariati hospital Tehran University of Medical Sciences Describe the typical imaging findings of GIST at initial
More informationObjectives. Intraoperative Consultation of the Whipple Resection Specimen. Pancreas Anatomy. Pancreatic ductal carcinoma 11/10/2014
Intraoperative Consultation of the Whipple Resection Specimen Pathology Update Faculty of Medicine, University of Toronto November 15, 2014 John W. Wong, MD, FRCPC Department of Anatomical Pathology Sunnybrook
More informationEXPression ANalyzer and DisplayER
EXPression ANalyzer and DisplayER Tom Hait Aviv Steiner Igor Ulitsky Chaim Linhart Amos Tanay Seagull Shavit Rani Elkon Adi Maron-Katz Dorit Sagir Eyal David Roded Sharan Israel Steinfeld Yossi Shiloh
More informationGIST PDX Models. Discover the world s most comprehensive GIST PDX collection, fully characterized for KIT mutations
GIST PDX Models Discover the world s most comprehensive GIST PDX collection, fully characterized for KIT mutations Accelerate your GIST targeted agent drug discovery programs with CrownBio s panel of well
More informationNational Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant
National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation Annual Progress Report: 2009 Formula Grant Reporting Period July 1, 2011 June 30, 2012 Formula Grant Overview The National Surgical
More informationSolitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation
246) Prague Medical Report / Vol. 113 (2012) No. 3, p. 246 250 Solitary Fibrous Tumor of the Kidney with Massive Retroperitoneal Recurrence. A Case Presentation Sfoungaristos S., Papatheodorou M., Kavouras
More informationLarge Colorectal Adenomas An Approach to Pathologic Evaluation
Anatomic Pathology / LARGE COLORECTAL ADENOMAS AND PATHOLOGIC EVALUATION Large Colorectal Adenomas An Approach to Pathologic Evaluation Elizabeth D. Euscher, MD, 1 Theodore H. Niemann, MD, 1 Joel G. Lucas,
More informationCase # nd Annual SEVPAC May 17, Kathy-Anne Clarke
Case # 10 42 nd Annual SEVPAC May 17, 2014 Kathy-Anne Clarke Google images Babu Babu is 10 year old spayed female French Bulldog Chronic weight loss over 4 months Febrile and lethargic at the referring
More informationA 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
More informationLeiomyosarcoma usually arises in the uterus, gastrointestinal
Case Report 430 Lower Gastrointestinal Bleeding due to Small Bowel Metastasis from Leiomyosarcoma in the Tibia Kun-Chun Chiang, MD; Chun-Nan Yeh, MD; Hsin-Nung Shih 1, MD; Yi-Yin Jan, MD; Miin-Fu Chen,
More informationANATOMICAL PATHOLOGY TARIFF
ANATOMICAL PATHOLOGY TARIFF A GUIDE TO UTILISATION. The following guidelines have been agreed by consensus of Anatomical Pathologists who are members of the Anatomical Pathologist s Group, or the National
More informationA 25 year old female with a palpable mass in the right lower quadrant of her abdomen
May 2016 A 25 year old female with a palpable mass in the right lower quadrant of her abdomen Contributed by: Paul Ndekwe, MD, Resident Physician, Indiana University School of Department of Pathology and
More informationIntussuception due to gastrointestinal stromal tumor with neural differentiation in a patient with. Von Recklinghausen Neurofibromatosis,
Turkish Journal of Cancer Vol 31/ No.4 /2001 Intussuception due to gastrointestinal stromal tumor with neural differentiation in a patient with Von Recklinghausen Neurofibromatosis (NF-1): A case report
More informationGeisinger Clinic Annual Progress Report: 2011 Nonformula Grant
Geisinger Clinic Annual Progress Report: 2011 Nonformula Grant Reporting Period July 1, 2012 June 30, 2013 Nonformula Grant Overview The Geisinger Clinic received $1,000,000 in nonformula funds for the
More informationInvited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases
Histol Histopathol (1 998) 13: 1077-1 087 http://www.ehu.es/histoi-histopathol Histology and Histopathology Invited Re vie W Analytical histopathological diagnosis of small hepatocellular nodules in chronic
More informationEstimating the Number of Clusters in DNA Microarray Data
Estimating the Number of Clusters in DNA Microarray Data N. Bolshakova 1, F. Azuaje 2 1 Department of Computer Science, Trinity College Dublin, Ireland 2 School of Computing and Mathematics, University
More informationGene expression analysis. Roadmap. Microarray technology: how it work Applications: what can we do with it Preprocessing: Classification Clustering
Gene expression analysis Roadmap Microarray technology: how it work Applications: what can we do with it Preprocessing: Image processing Data normalization Classification Clustering Biclustering 1 Gene
More informationDevelopment and Application of an Enteric Pathogens Microarray
Development and Application of an Enteric Pathogens Microarray UC Berkeley School of Public Health Sona R. Saha, MPH Joseph Eisenberg, PhD Lee Riley, MD Alan Hubbard, PhD Jack Colford, MD PhD East Bay
More informationSpecialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery for treatment of Pseudomyxoma Peritonei
Specialised Services Policy: CP02 Hyperthermic Intraperitoneal Chemotherapy (HIPEC) of Pseudomyxoma Peritonei Document Author: Assistant Medical Director Executive Lead: Medical Director Approved by: Management
More informationStatistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies
Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies Stanford Biostatistics Workshop Pierre Neuvial with Henrik Bengtsson and Terry Speed Department of Statistics, UC Berkeley
More informationCatholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.
Anatomopathology Pathology 1 Anatomopathology Biopsies Frozen section Surgical specimen Peculiarities for various tumor site References Pathology 2 Biopsies Minimum data, which should be given by the pathologist
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationClinical Trials. Phase II Studies. Connective Tissue Oncology Society. Jon Trent, MD, PhD
Clinical Trials Phase II Studies Jon Trent, MD, PhD Associate Professor Dept. of Sarcoma Medical Oncology The University of Texas, M. D. Anderson Cancer Center Connective Tissue Oncology Society GIST Overview
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationIN SPITE of a very quick development of medicine within
INTL JOURNAL OF ELECTRONICS AND TELECOMMUNICATIONS, 21, VOL. 6, NO. 3, PP. 281-286 Manuscript received July 1, 21: revised September, 21. DOI: 1.2478/v1177-1-37-9 Application of Density Based Clustering
More informationProduct Introduction
Product Introduction Product Codes: HCL026, HCL027 and HCL028 Contents Introduction to HER2 2 HER2 immunohistochemistry 3 Cell lines as controls 5 HER2 Analyte Control DR IHC 7 HER2 Analyte Control DR
More informationOFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM
OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM Name: _, OFCCR # _ OCGN # _ OCR Group # _ HIN# Sex: MALE FEMALE UNKNOWN Date of Birth: DD MMM YYYY BASELINE DIAGNOSIS & TREATMENT 1. Place of Diagnosis: Name
More informationPractical Experience in the Analysis of Gene Expression Data
Workshop Biometrical Analysis of Molecular Markers, Heidelberg, 2001 Practical Experience in the Analysis of Gene Expression Data from Two Data Sets concerning ALL in Children and Patients with Nodules
More informationIMATINIB MESYLATE THERAPY IN ADVANCED GASTROINTESTINAL STROMAL TUMORS: EXPERIENCE FROM A SINGLE INSTITUTE
IMATINIB MESYLATE THERAPY IN ADVANCED GASTRINTESTINAL STRMAL TUMRS: EXPERIENCE FRM A SINGLE INSTITUTE Hui-Hua Hsiao, 1,2 Yi-Chang Liu, 2 Hui-Jen Tsai, 2 Li-Tzong Chen, 1,2 Ching-Ping Lee, 2 Chieh-Han Chuan,
More informationClinical Study Small Bowel Tumors: Clinical Presentation, Prognosis, and Outcomein33PatientsinaTertiaryCareCenter
Hindawi Publishing Corporation Journal of Oncology Volume 2008, Article ID 212067, 5 pages doi:10.1155/2008/212067 Clinical Study Small Bowel Tumors: Clinical Presentation, Prognosis, and Outcomein33PatientsinaTertiaryCareCenter
More informationDiagnosis and management of retroperitoneal sarcoma
SON Update 2017 Diagnosis and management of retroperitoneal sarcoma Andrea J MacNeill, MD MSc FRCSC Surgical Oncologist, BC Cancer Agency Vancouver 2 Histologic Subtypes of STS 3 RP Subtypes (n=684) Extremity
More informationGastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors
Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Jaume Capdevila, MD, PhD Vall d'hebron University Hospital Vall d'hebron Institute of Oncology (VHIO)
More informationRadio-Pathologic Workup of a Retroperitoneal Abdominal Mass
Radio-Pathologic Workup of a Retroperitoneal Abdominal Mass Joe Carlson Advanced Radiology Clerkship Harvard Medical School Year IV September 12, 2002 84 year old Male Presented to PCP With Abdominal Pain
More informationProtocol for the Examination of Specimens From Patients With Gastrointestinal Stromal Tumor (GIST)
Protocol for the Examination of Specimens From Patients With Gastrointestinal Stromal Tumor (GIST) Version: Protocol Posting Date: June 2017 Includes ptnm requirements from the 8 th Edition, AJCC Staging
More information